Category: us corporate news

us corporate news

Sleep Number Unveils Turnaround Strategy for 2026: Simplified Product Line, Cost Reductions, and Growth Initiatives to Drive Shareholder Value

Minichart

March 13, 2026

Sleep Number Corporation Releases Investor Presentation: Agg...

Continue Reading 0

us corporate news

Matson, Inc. Form 8-K Filing Details for March 9, 2026 – Company Information, Stock, and SEC Compliance

Minichart

March 13, 2026

Matson, Inc. 8-K Report Analysis: EVP Retirement Announcemen...

Continue Reading 0

us corporate news

Paycom Software, Inc. Announces Entry into Material Definitive Agreement – 8-K Filing Details March 12, 2026

Minichart

March 13, 2026

Paycom Software, Inc. Announces Increasing Lender Supplement...

Continue Reading 0

us corporate news

Digimarc Corporation Announces Holding Company Reorganization Plan and Merger Agreement for Shareholder Vote in 2026

Minichart

March 13, 2026

Digimarc Corporation Announces Proposed Holding Company Reor...

Continue Reading 0

us corporate news

Hallador Energy Reports Record 2025 Revenue, 3x EBITDA Growth, and Announces 515MW Gas Expansion at Merom Power Plant

Minichart

March 13, 2026

Hallador Energy Company Reports Strong FY2025 Results, Annou...

Continue Reading 0

us corporate news

KORU Medical Systems 2025 Annual Report: Key Risks, Business Strategy, and Regulatory Compliance Overview

Minichart

March 13, 2026

KORU Medical Systems, Inc. - 2025 Annual Report: Key Points ...

Continue Reading 0

us corporate news

OnKure Therapeutics, Inc. 2025 Annual Report: Precision Oncology Pipeline and Focus on PI3Kα Inhibitors

Minichart

March 13, 2026

Okur Therapeutics 2025 Annual Report: Key Highlights for Inv...

Continue Reading 0

us corporate news

Citizens, Inc. 2025 Annual Report: Business Overview, Strategic Initiatives, and Financial Highlights

Minichart

March 13, 2026

Citizens, Inc. 2025 Annual Report Analysis: Key Insights for...

Continue Reading 0

us corporate news

Erasca, Inc. 2025 Annual Report: Erasing Cancer with Modality-Agnostic RAS/MAPK Pathway Therapeutics and Innovative Precision Oncology Strategies

Minichart

March 13, 2026

Erasca, Inc. 2025 Annual Report: Key Developments and Invest...

Continue Reading 0

us corporate news

Allogene Therapeutics 2025 Annual Report: Advancing Allogeneic CAR T Cell Therapies for Cancer and Autoimmune Diseases

Minichart

March 13, 2026

Allogene Therapeutics, Inc. 2025 Annual Report – Key Financi...

Continue Reading 0